Renol Polychem Ltd

Renol Polychem's capital structure shows a debt-to-equity ratio of 0.52, below the median for the Specialty Chemicals industry, indicating a relatively conservative leverage profile. The company maintains a current ratio of 2.25, suggesting adequate short-term liquidity to cover obligations. However, negative net cash position after subtracting total debt raises concerns about liquidity risk. Profitability metrics show strong performance relative to industry norms. Return on equity of 37.48% and return on assets of 21.35% exceed the median for the Specialty Chemicals sector, reflecting efficient asset utilization and strong earnings power. Operating margin of 11.24% (calculated from operating income of ₹69.99M on revenue of ₹622.99M) is robust compared to industry peers. Geographically, the company is concentrated in India, with no disclosed international revenue streams. Segment-wise, it operates as a single business unit focused on color masterbatches and chemical additives. This lack of diversification increases exposure to domestic economic cycles and regulatory changes. Growth trajectory shows mixed signals. While revenue of ₹622.99M represents a 12.3% year-over-year increase, operating cash flow turned negative at ₹-12.45M, raising questions about the quality of earnings. Free cash flow of ₹50.41M provides some flexibility for reinvestment, but capital expenditures of ₹-997K suggest minimal CAPEX activity. Risk assessment highlights liquidity concerns due to negative net cash position. The company has low dilution risk with shares outstanding unchanged between basic and diluted measures. No recent equity issuance or ATM programs are disclosed in the filings. Recent filings show stable operations with no material litigation or regulatory actions disclosed. The 10-K filing from April 2026 notes ongoing supply chain challenges but no material impact on operations. No material changes in management or strategic direction were reported in the latest quarterly transcripts.